FTC, FDA Move Against Dozens of Supplement Firms Making False COVID-19 Claims

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

FTC, FDA Move Against Dozens of Supplement Firms Making False COVID-19 Claims

Under Consent Degree, Firm Will Stop Marketing Drugs, Supplements as COVID-19 Treatments

Darla M. Fera

January 21, 2021 at 10:08 AM EST

The Federal Trade Commission (FTC) and the FDA are continuing to stay busy monitoring marketing activities, particularly website offerings, and moving against companies, many of them supplement firms, making allegedly false claims about products that purportedly treat or cure COVID-19. Last November, for example, the FTC announced that it had moved against 20 companies to st... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

FTC, FDA Move Against Dozens of Supplement Firms Making False COVID-19 Claims

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT